Angiology: Open Access
Open Access

Explaining the Impact: Ninjurin 2 Polymorphisms and Susceptibility to Coronary Heart Disease

Cynthia Georgia^{* *}Correspondence: Cynthia Georgia, Department of Cardiology, Başkent University, Ankara, Turkey, Email:

Author info »

Description

Coronary Heart Disease (CHD) remains a leading cause of mortality worldwide, posing a significant public health challenge. Despite advances in medical science, the intricate interplay between genetic predisposition and environmental factors continues to intrigue researchers. Recently, attention has turned to Ninjurin 2 (NINJ2) polymorphisms, a gene implicated in various inflammatory processes, as a potential player in CHD susceptibility. This article delves into the emerging research surrounding the effects of NINJ2 polymorphisms on the risk of developing coronary heart disease.

Understanding ninjurin 2

Ninjurin 2(NINJ2), a gene located on chromosome 12p13.31, encodes for Ninjurin 2 protein, primarily expressed in immune cells and endothelial cells. While its precise physiological role remains under investigation, studies have highlighted its involvement in inflammation, immune responses, and neurodegenerative disorders. Notably, NINJ2 has been linked to atherosclerosis, the underlying pathology of CHD, suggesting a potential association between NINJ2 polymorphisms and CHD susceptibility.

Exploring the genetic landscape: Genome-wide Association Studies (GWAS) and candidate gene approaches have explained on the genetic variants within NINJ2 and their relationship with CHD. Polymorphisms such as rs11833579 and rs12425791 have garnered attention for their potential influence on CHD risk. These Single Nucleotide Polymorphisms (SNPs) may alter gene expression, protein function, or regulatory mechanisms, thereby modulating inflammatory pathways implicated in atherogenesis.

Clinical implications: Evidence supporting the association between NINJ2 polymorphisms and CHD susceptibility is accumulating, although findings remain somewhat inconsistent across populations. Some studies have reported significant associations between specific NINJ2 variants and increased CHD risk, while others have failed to replicate these findings. Moreover, interactions between NINJ2 polymorphisms and traditional risk factors, such as hypertension, dyslipidemia, and diabetes, further complicate the picture, highlighting the multifactorial nature of CHD pathogenesis.

Mechanistic insights: The precise mechanisms underlying the influence of NINJ2 polymorphisms on CHD susceptibility are not fully understood. However, emerging research suggests potential pathways through which NINJ2 variants may contribute to atherosclerosis. These include enhanced leukocyte recruitment and adhesion to the endothelium, augmented inflammatory cytokine production, and altered plaque stability, all of which could promote the development and progression of CHD.

Future directions: As research in this field progresses, several avenues warrant exploration. Large-scale, multiethnic cohort studies are needed to elucidate the population-specific effects of NINJ2 polymorphisms on CHD susceptibility. Additionally, functional studies investigating the biological consequences of NINJ2 variants, such as their impact on immune cell activation and vascular inflammation, are essential for a comprehensive understanding of their role in CHD pathogenesis. Integrating genetic information into risk prediction models may also refine CHD risk stratification and guide personalized preventive strategies tailored to an individual's genetic profile.

Conclusion

NINJ2 polymorphisms represent a prominent area of research in the quest to unravel the complex genetic architecture of coronary heart disease. While evidence supporting their association with CHD susceptibility continues to accumulate, further studies are warranted to elucidate the underlying mechanisms and clinical implications fully. By unraveling the intricate interplay between genetic factors, inflammation, and atherosclerosis, researchers strive to pave the way for more effective prevention and management strategies for this pervasive cardiovascular disorder.